|
1 |
PK-HCQ Study |
PI: Dr. Denis Xavier; Dr. Bhuvana KB |
Year of Completion 2020 |
|
2 |
ACT Study - Anti-Coronavirus Therapies (ACT) to prevent progression of COVID-19: Randomized trials |
PI: Dr. Denis Xavier, Co-I: Dr. Prem Pais / Dr.Atiya Faruqui/ Dr. Bhuvana K B |
2020-2022 |
|
3 |
RUMC - Rational use of Medicine Centres |
PI: Dr Denis Xavier; Co-I: Dr. Padmini Devi, Dr.Atiya Faruqui, Dr. Mangala Rao |
2019-2022 |
|
4 |
An Interventional, Randomized, Parallel Group, Placebo Controlled, Three Arm Clinical Study of Beverage Formulations (Formulation 1A and Formulation 1B) to Assess Their Properties towards the Enhancement of Active Energy and Improving Immunity in Healthy Population - HBS 1 |
Dr. Denis Xavier, Dr. Pawan Kumar Godatwar, National institute of Ayurveda, Jaipur |
2019 |
|
5 |
STRIDE – Study of the effect of topical warm oxygen in treatment of diabetic foot ulcer |
Dr. Denis Xavier, Dr. Deepak Kamath |
2019 |
|
6 |
An Interventional, Randomized, Parallel Group, Placebo Controlled, Three Arm Clinical Study of Beverage Formulations (Formulation 3A and Formulation 3B) to assess reduction in stress and improvement in immunity in Healthy Population – HBS 3 |
Dr. Denis Xavier, Dr. Pawan Kumar Godatwar, National institute of Ayurveda, Jaipur |
2019 |
|
7 |
An Interventional, Randomized, Parallel Group, Placebo Controlled, Three Arm Clinical Study of Beverage Formulations (Formulation 2A and Formulation 2B) to Assess Improvement in Immunity and Management of General Health in Healthy Population - HBS 2 |
Dr. Denis Xavier, Dr. Pawan Kumar Godatwar, National institute of Ayurveda, Jaipur |
2019 |
|
8 |
IMPACT AF: Clustered Randomized Trial Protocol |
PI: Dr. Denis Xavier, Co-I: Dr. Deepak Kamath |
2017 |
|
9 |
PANACEA-HF (Piloting a quality improvement intervention for the optimal treatment of patients with chronic heart failure) |
PI: Dr. Deepak Kamath, Co-PI: Dr. Denis Xavier, Dr. Bhuvana K B |
2016-2023 |
|
10 |
Heart Rescue - An impact evaluation of the Heart Rescue India program: Assessing the effectiveness of a quality improvement program to improve access and care of acute cardiovascular disease |
PI: Dr. Denis Xavier, Co-I: Dr. Padmini Devi/ Dr. Ramakrishna Goud/ Dr. Twinkle Agrawal/ Dr. Farah F |
2016-2020 |
|
11 |
ENDORSE - Effect of behavioural interveNtion on medication aDherence amOng eldeRly with Select non-communicable disEases - Pilot Randomised Controlled Trial |
Dr. Jeffrey Pradeep Raj, Dr. Denis Xavier, Dr. Betsy Mathew |
2016 |
|
12 |
CARE - Cardiovascular Disease: Assessment of Risk factors in Estate workers - Cross sectional study |
Dr. Denis Xavier, Dr. Sitarah Mathias, Dr. Akhil Xavier Joseph, Dr. Tanvi Jadhav, Dr. Prem Pais |
2015 |
|
13 |
AUGUSTUS - Apixaban versus Vitamin K Antagonist in Atrial Fibrillation ACS / PCI |
Dr. Denis Xavier; Dr. Atiya Faruqui |
2015 |
|
14 |
PROGRESS - Policy and peeR mentor intervention proGrams on cardiovascular disease at work Sites in 3 South Asian countries |
PI: Dr. Denis Xavier, Co-I: Dr. Deepak Kamath, Dr. Padmini Devi |
2014 |
|
15 |
MANAGE - Management of myocardial injury After NoncArdiac surGEry Trial |
Dr. Denis Xavier, Dr. Mangala Rao |
2014 |